University Hospital Zurich, Division of Dermatology
Zurich, Canton of Zurich, 8091, Switzerland
NCT Number: NCT01976481
Our study aims to clarify the impact of the use of a standard sunbed according to new EU guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new recommendations for the exposure plan for different skin types according to EN 60335-2-27.
The use of a sunbed will be compared to a control group not using a sunbed in the observation period.
* Trial with medical device
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Zurich, Canton of Zurich, 8091, Switzerland
We will compare to baseline changes in serum vitamin D and health-related quality of life using a control group and an intervention group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Probands intending to use a commercial sunbed :
Exclusion criteria
1. Skin type I according to Fitzpatrick according to EU guideline EN 60335-2-27 2. Sunbed use within the last three months 3. Use of vitamin D supplements or multivitamin supplements 4. Any medical condition which renders them unfit for sunbed use in the judgment of the investigator 5. Inability to provide oral and written consent to participate
exposure to sunbed ultraviolet radiation
Time frame: six months
University of Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05109858
Skin Toxicity
Merano, Bolzano, Italy
View Trial DetailsNCT04929847
Neoplasms, Skin Toxicity
Hasselt, Limburg, Belgium
View Trial DetailsNCT03448731
Skin Toxicity
Algeciras, Spain
View Trial DetailsNCT00871429
Skin Toxicity
Chicago, Illinois, United States
View Trial Details